IT8422744A0 - 4(3h)-pirimidoni 2,5-disostituiti aventi attivita' antagonista dei recettori della istamina h2. - Google Patents

4(3h)-pirimidoni 2,5-disostituiti aventi attivita' antagonista dei recettori della istamina h2.

Info

Publication number
IT8422744A0
IT8422744A0 IT8422744A IT2274484A IT8422744A0 IT 8422744 A0 IT8422744 A0 IT 8422744A0 IT 8422744 A IT8422744 A IT 8422744A IT 2274484 A IT2274484 A IT 2274484A IT 8422744 A0 IT8422744 A0 IT 8422744A0
Authority
IT
Italy
Prior art keywords
dissustituted
pyrimidones
histamine
receptors
antagonist activity
Prior art date
Application number
IT8422744A
Other languages
English (en)
Other versions
IT8422744A1 (it
IT1176739B (it
Inventor
Aldo A Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IT8422744A0 publication Critical patent/IT8422744A0/it
Publication of IT8422744A1 publication Critical patent/IT8422744A1/it
Application granted granted Critical
Publication of IT1176739B publication Critical patent/IT1176739B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT22744/84A 1983-09-21 1984-09-20 4(3h)-pirimidoni 2,5-disostituiti aventi attivita' antagonista dei recettori della istamina h2 IT1176739B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/534,426 US4772704A (en) 1983-09-21 1983-09-21 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity

Publications (3)

Publication Number Publication Date
IT8422744A0 true IT8422744A0 (it) 1984-09-20
IT8422744A1 IT8422744A1 (it) 1986-03-20
IT1176739B IT1176739B (it) 1987-08-18

Family

ID=24129972

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22744/84A IT1176739B (it) 1983-09-21 1984-09-20 4(3h)-pirimidoni 2,5-disostituiti aventi attivita' antagonista dei recettori della istamina h2

Country Status (36)

Country Link
US (1) US4772704A (it)
JP (1) JPH0643310B2 (it)
KR (1) KR900001198B1 (it)
AR (2) AR242385A1 (it)
AT (1) AT387965B (it)
AU (1) AU583479B2 (it)
BE (1) BE900652A (it)
CA (1) CA1260463A (it)
CH (1) CH665840A5 (it)
CS (1) CS249147B2 (it)
CY (1) CY1561A (it)
DD (1) DD226881A5 (it)
DE (1) DE3434578A1 (it)
DK (1) DK162987C (it)
ES (4) ES8607253A1 (it)
FI (1) FI83868C (it)
FR (1) FR2552082B1 (it)
GB (1) GB2146994B (it)
GR (1) GR80439B (it)
HK (1) HK73790A (it)
HU (1) HU193227B (it)
IE (1) IE58083B1 (it)
IL (1) IL72990A (it)
IT (1) IT1176739B (it)
LU (1) LU85550A1 (it)
NL (1) NL8402898A (it)
NO (1) NO161561C (it)
NZ (1) NZ209572A (it)
OA (1) OA07820A (it)
PT (1) PT79256B (it)
SE (1) SE463209B (it)
SG (1) SG60890G (it)
YU (1) YU45205B (it)
ZA (1) ZA847345B (it)
ZM (1) ZM4984A1 (it)
ZW (1) ZW16084A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2873340B2 (ja) * 1988-04-29 1999-03-24 武田薬品工業株式会社 抗生物質tan―1057,その製造法および用途
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (it) * 1978-02-13 1983-03-05 Smith Kline French Lab
ES477520A1 (es) * 1978-02-25 1979-06-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevas penicilinas.
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
AU531142B2 (en) * 1979-04-04 1983-08-11 Smith Kline & French Laboratories Limited 2 amino- pyimindones
CA1140129A (en) * 1979-08-21 1983-01-25 Ronald J. King 4-pyrimidone derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4468399A (en) * 1981-12-28 1984-08-28 Eli Lilly And Company 2-[2-(2-Aminoalkyl-4-thiazolylmethylthio)alkyl]-amino-5-substituted-4-pyrimidones
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
CA1275097A (en) * 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives

Also Published As

Publication number Publication date
IT8422744A1 (it) 1986-03-20
DK450484D0 (da) 1984-09-20
SE8404729L (sv) 1985-03-22
FR2552082A1 (fr) 1985-03-22
DK162987B (da) 1992-01-06
IL72990A (en) 1990-07-12
HUT35259A (en) 1985-06-28
CA1260463A (en) 1989-09-26
HU193227B (en) 1987-08-28
FR2552082B1 (fr) 1987-02-20
KR850002259A (ko) 1985-05-10
ES8702897A1 (es) 1987-01-16
GB2146994A (en) 1985-05-01
SG60890G (en) 1990-09-07
ES544213A0 (es) 1987-04-01
AT387965B (de) 1989-04-10
IE842406L (en) 1985-03-21
AR242789A1 (es) 1993-05-31
YU45205B (en) 1992-05-28
AU3335184A (en) 1985-03-28
CS249147B2 (en) 1987-03-12
ES8704465A1 (es) 1987-04-01
ES8607253A1 (es) 1986-05-16
IT1176739B (it) 1987-08-18
HK73790A (en) 1990-09-28
NL8402898A (nl) 1985-04-16
YU161384A (en) 1987-12-31
LU85550A1 (fr) 1985-06-04
DD226881A5 (de) 1985-09-04
DK162987C (da) 1992-06-01
JPH0643310B2 (ja) 1994-06-08
KR900001198B1 (ko) 1990-02-28
US4772704A (en) 1988-09-20
ZA847345B (en) 1985-06-26
NO161561B (no) 1989-05-22
NZ209572A (en) 1988-05-30
CH665840A5 (de) 1988-06-15
FI83868B (fi) 1991-05-31
BE900652A (fr) 1985-03-21
PT79256B (en) 1986-11-20
IE58083B1 (en) 1993-06-30
FI843643L (fi) 1985-03-22
ZM4984A1 (en) 1985-05-21
SE8404729D0 (sv) 1984-09-20
PT79256A (en) 1984-10-01
FI843643A0 (fi) 1984-09-18
GR80439B (en) 1985-01-22
ES551500A0 (es) 1987-03-16
ATA300984A (de) 1988-09-15
ES536054A0 (es) 1986-05-16
CY1561A (en) 1991-03-22
ZW16084A1 (en) 1985-01-16
ES551501A0 (es) 1987-01-16
AR242385A1 (es) 1993-03-31
SE463209B (sv) 1990-10-22
OA07820A (fr) 1986-11-20
GB8423863D0 (en) 1984-10-24
JPS6087271A (ja) 1985-05-16
DE3434578A1 (de) 1985-04-11
NO843726L (no) 1985-03-22
NO161561C (no) 1989-08-30
AU583479B2 (en) 1989-05-04
GB2146994B (en) 1987-09-03
FI83868C (fi) 1991-09-10
ES8704155A1 (es) 1987-03-16
DK450484A (da) 1985-03-22

Similar Documents

Publication Publication Date Title
FI852123A0 (fi) Inotropiska, kinoloninbaserade aemnen.
DE3584877D1 (de) Weggeber.
DE3574665D1 (de) Glutamatrezeptorshemmstoff.
NO852561L (no) Farmakologisk aktive, substituerte benzamider.
DE3587677D1 (de) Absorbierende Hygienevorlage.
IT8519908A0 (it) Procedimento per produrre difenilammine oppure n,n'-difenil-fenilendiammine.
NO860865L (no) Nye amidinforbindelser.
IT8523332A0 (it) Metodo per stabilire la validita'della sintesi tra due sorgenti disegnali indicativi di parametri.
IT1176739B (it) 4(3h)-pirimidoni 2,5-disostituiti aventi attivita' antagonista dei recettori della istamina h2
FI845095A7 (fi) Aminoimidatsolonijohdannaiset histamiini-H2-antagonisteina.
IT1164633B (it) 3,4-diammino-1,2,5-tiadiazoli dotati di attivita' antagonista dei recettori istaminici
NO852144L (no) Hoeydeinnstillbar soeyle for dreiestol.
FI861715L (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
OA08039A (fr) 3,4-diamido-1,2,5-thiadiazoles substitués présentant une activité antagoniste du récepteur H2 de l'histamine.
ES539074A0 (es) Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
ES522295A0 (es) Un derivado de trifluormetil-espiro(imidazolidina-4,3'-indolina)-2,2'5-triona.
IT8222035A0 (it) Procedimento perfezionato per lapreparazione della 2,4-diammino-5-(3',4',5'-trimetossi benzil)-pirimidina.
DK325784A (da) Cytosinderivater, som er histamin h2-antagonister
ES528938A0 (es) Procedimiento de obtencion de 4-(3-nitrofenil)-2,6-dimetil-1,4-dihidropiridin-3,5-dicarboxilato de 2-n-propoxietilo
ES548566A0 (es) Procedimiento de obtencio de etil-metil-1,4 dihidro-2,6-di- metil-4- (m-nitrofenil)-3,5 piridin carboxilato.
IT8422702A0 (it) Nuovi 2,3-diidro-1,4-benzodiossini 2,2-disostituiti ad attivita'ipotensiva.
IT8323109A0 (it) Nuovi 2,3-diidro-1,4-benzodiossini 2,2-disostituiti ad attivita'ipotensiva.
IT8523020A0 (it) Ascorbati antagonisti dei recettori h2 e procedimento per la loro preparazione.
IT8223991A0 (it) Nuovi 2,3-diidro-1,4-benzodiossini 2,2-disostituiti ad attivita'ipotensiva.
IT8025983A0 (it) Nuovi 2,3-diidro-1,4-benzodiossini-2,2-disostituiti ad attivita' ipotensiva.